| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0073 | 0.9 |